Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$755M Buy
+27,076,800
New +$721M 0.67% 42
2022
Q3
Sell
-500,000
Closed -$26.3M 1064
2022
Q2
$26.3M Buy
+500,000
New +$25.5M 0.05% 212
2018
Q1
Sell
-105,400
Closed -$3.63M 1174
2017
Q4
$3.63M Buy
+105,400
New +$3.59M 0.01% 417
2017
Q3
Sell
-316
Closed -$10K 931
2017
Q2
$10K Buy
+316
New +$9.96K ﹤0.01% 894

Other funds holding PFE

DZ Bank's PFE Position: Q1 2026 in Review

DZ Bank increased its Pfizer (PFE) stake by 5.4% in Q1 2026, buying an estimated $1.82M and bringing the position to 1,341,471 shares worth $37.6M. The position accounts for 0.03% of the portfolio, ranked #201.

DZ Bank first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $717M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • DZ Bank held 1,341,471 shares of Pfizer worth $37.6M as of Q1 2026.
  • DZ Bank bought 68,402 Pfizer shares in Q1 2026, an estimated $1.82M.
  • Pfizer made up 0.03% of DZ Bank's portfolio in Q1 2026, its #201 holding.
  • DZ Bank first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
  • DZ Bank's Pfizer position peaked at $717M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.